The Use of New Technologies in the Study of Pregnancy Disorders: The OMICS Approach

<p>The "omics" technologies represent a new model of approach in the study of human disease. It consists of general approaches on molecules (such as genes, transcripts, proteins and metabolites) of which a cell, tissue or organism is made. Although the interactions between the '...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Silvia Visentin (Yazar), Maria Caterina Bongiorno (Yazar), Maria Calanducci (Yazar), Loris Marin (Yazar), Erich Cosmi (Yazar)
Materyal Türü: Kitap
Baskı/Yayın Bilgisi: Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications, 2017-02-08.
Konular:
Online Erişim:Connect to this object online.
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_2455-2976_000035
042 |a dc 
100 1 0 |a Silvia Visentin  |e author 
700 1 0 |a  Maria Caterina Bongiorno  |e author 
700 1 0 |a  Maria Calanducci  |e author 
700 1 0 |a  Loris Marin  |e author 
700 1 0 |a Erich Cosmi  |e author 
245 0 0 |a The Use of New Technologies in the Study of Pregnancy Disorders: The OMICS Approach 
260 |b Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications,   |c 2017-02-08. 
520 |a <p>The "omics" technologies represent a new model of approach in the study of human disease. It consists of general approaches on molecules (such as genes, transcripts, proteins and metabolites) of which a cell, tissue or organism is made. Although the interactions between the 'omes' mean that omic strategies are complementary, there are differences in terms of their molecular properties, and therefore, the technologies required for preparation and analysis [1]. Metabolomics is defined as the quantitative measurement of the dynamic metabolic response of living systems to genetic, physical, pathological or developmental factors. The technology has emerged in numerous fi elds of research, including fetal medicine aiming to facilitate the understanding of fetal disease pathophysiology and discovery of  redictive biomarkers [2].</p> 
540 |a Copyright © Silvia Visentin et al. 
546 |a en 
655 7 |a Review Article  |2 local 
856 4 1 |u https://doi.org/10.17352/2455-2976.000035  |z Connect to this object online.